
Evidence analysis
EU: Countries Plan Rwanda Deportation Centers
Evidence Dossier: EU Countries Plan Rwanda Deportation Centers What is established In November 2026, Austria, Denmark, Germany, Greece, and the Netherlands confirmed ongoing negotiations with Rwanda to establish offshore deportation centers on Rwandan territory. This plan involves sending…
Read →
Evidence analysis
Bangladesh: Education Crisis for Rohingya Refugee Children
Evidence Dossier: Education for Rohingya Refugee Children in Bangladesh What is established Human Rights Watch has reported a significant education crisis affecting Rohingya refugee children living in Bangladesh’s Cox’s Bazar camps as of late 2026. The camps host…
Read →
Evidence analysis
‘He used Pornhub as the gun’
Evidence Dossier: Pornhub and the Spread of Child Sexual Abuse and Nonconsensual Videos This dossier reviews information disclosed by the International Consortium of Investigative Journalists (ICIJ) on November 16, 2026, regarding the operation of Pornhub and its parent…
Read →
Evidence analysis
Iraq Cracks Down on Oil Smuggling in Area Controlled by Iran-aligned Shiite Militias
Evidence Dossier: Iraq’s Crackdown on Oil Smuggling in Iran-aligned Militia Areas What is established In November 2026, the Iraqi government announced a crackdown on oil smuggling operations in the district of Jurf al-Nasr, located about 30 miles southwest…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 13, Status: Authorised
What is established On August 22, 2024, the European Medicines Agency (EMA) authorised mResvia, a messenger RNA (mRNA) vaccine designed to prevent respiratory syncytial virus (RSV) infections. RSV is a common cause of respiratory tract infections, particularly in…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 22, Status: Authorised
Evidence Dossier: Leflunomide ratiopharm – European Medicines Agency Assessment What is established Leflunomide ratiopharm is a generic pharmaceutical medicine authorized for use within the European Union, containing the active substance leflunomide. It is used under prescription, primarily for…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Revision: 3, Status: Authorised
What is established Kisunla, containing the active substance donanemab, is an approved medicine in the European Union for treating adults with mild cognitive impairment or mild dementia due to early Alzheimer’s disease. It is authorized specifically for patients…
Read →
Evidence analysis
European SARS-CoV-2 and influenza virus Bioinformatics External Quality Assessment (ESIB-EQA), 2025
European SARS-CoV-2 and Influenza Virus Bioinformatics External Quality Assessment (ESIB-EQA), 2025 This article examines the 2025 report from the European Centre for Disease Prevention and Control (ECDC) on the European SARS-CoV-2 and influenza virus Bioinformatics External Quality Assessment…
Read →
Evidence analysis
The Students Beat the Strongman. Now What? Five Questions on What Comes Next For Serbia
Accountability in Serbia: Challenges and Opportunities following a Political Shift In late 2026, Serbia witnessed a significant political upheaval when a new, student-backed political party decisively defeated the entrenched Serbian Progressive Party (SNS), bringing an end to over…
Read →
Evidence analysis
UAE: 5 Shia Residents Arrested Arbitrarily
Human Rights Concerns: Arbitrary Arrests of Shia Residents in the United Arab Emirates What is established According to a report published by Human Rights Watch on November 16, 2026, Emirati authorities have arbitrarily detained at least five Shia…
Read →